Global Point-of-care Cancer Screening Market 2023 by Company, Regions, Type and Application, Forecast to 2029

1 Market Overview

• 1.1 Product Overview and Scope of Point-of-care Cancer Screening
• 1.2 Market Estimation Caveats and Base Year
• 1.3 Classification of Point-of-care Cancer Screening by Type
  • 1.3.1 Overview: Global Point-of-care Cancer Screening Market Size by Type: 2018 Versus 2022 Versus 2029
  • 1.3.2 Global Point-of-care Cancer Screening Consumption Value Market Share by Type in 2022
  • 1.3.3 Genetic Screening
  • 1.3.4 Image Screening
  • 1.3.5 Others
• 1.4 Global Point-of-care Cancer Screening Market by Application
  • 1.4.1 Overview: Global Point-of-care Cancer Screening Market Size by Application: 2018 Versus 2022 Versus 2029
  • 1.4.2 Hospital
  • 1.4.3 Clinic
  • 1.4.4 Others
• 1.5 Global Point-of-care Cancer Screening Market Size & Forecast
• 1.6 Global Point-of-care Cancer Screening Market Size and Forecast by Region
  • 1.6.1 Global Point-of-care Cancer Screening Market Size by Region: 2018 VS 2022 VS 2029
  • 1.6.2 Global Point-of-care Cancer Screening Market Size by Region, (2018-2029)
  • 1.6.3 North America Point-of-care Cancer Screening Market Size and Prospect (2018-2029)
  • 1.6.4 Europe Point-of-care Cancer Screening Market Size and Prospect (2018-2029)
  • 1.6.5 Asia-Pacific Point-of-care Cancer Screening Market Size and Prospect (2018-2029)
  • 1.6.6 South America Point-of-care Cancer Screening Market Size and Prospect (2018-2029)
  • 1.6.7 Middle East and Africa Point-of-care Cancer Screening Market Size and Prospect (2018-2029)

2 Company Profiles

• 2.1 Hologic Corporation
  • 2.1.1 Hologic Corporation Details
  • 2.1.2 Hologic Corporation Major Business
  • 2.1.3 Hologic Corporation Point-of-care Cancer Screening Product and Solutions
  • 2.1.4 Hologic Corporation Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.1.5 Hologic Corporation Recent Developments and Future Plans
• 2.2 Abbott Laboratories
  • 2.2.1 Abbott Laboratories Details
  • 2.2.2 Abbott Laboratories Major Business
  • 2.2.3 Abbott Laboratories Point-of-care Cancer Screening Product and Solutions
  • 2.2.4 Abbott Laboratories Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.2.5 Abbott Laboratories Recent Developments and Future Plans
• 2.3 Qiagen N.V.
  • 2.3.1 Qiagen N.V. Details
  • 2.3.2 Qiagen N.V. Major Business
  • 2.3.3 Qiagen N.V. Point-of-care Cancer Screening Product and Solutions
  • 2.3.4 Qiagen N.V. Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.3.5 Qiagen N.V. Recent Developments and Future Plans
• 2.4 F Hoffmann-La Roche
  • 2.4.1 F Hoffmann-La Roche Details
  • 2.4.2 F Hoffmann-La Roche Major Business
  • 2.4.3 F Hoffmann-La Roche Point-of-care Cancer Screening Product and Solutions
  • 2.4.4 F Hoffmann-La Roche Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.4.5 F Hoffmann-La Roche Recent Developments and Future Plans
• 2.5 BD
  • 2.5.1 BD Details
  • 2.5.2 BD Major Business
  • 2.5.3 BD Point-of-care Cancer Screening Product and Solutions
  • 2.5.4 BD Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.5.5 BD Recent Developments and Future Plans
• 2.6 Quest Diagnostics
  • 2.6.1 Quest Diagnostics Details
  • 2.6.2 Quest Diagnostics Major Business
  • 2.6.3 Quest Diagnostics Point-of-care Cancer Screening Product and Solutions
  • 2.6.4 Quest Diagnostics Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.6.5 Quest Diagnostics Recent Developments and Future Plans
• 2.7 OncoHealth Corp
  • 2.7.1 OncoHealth Corp Details
  • 2.7.2 OncoHealth Corp Major Business
  • 2.7.3 OncoHealth Corp Point-of-care Cancer Screening Product and Solutions
  • 2.7.4 OncoHealth Corp Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.7.5 OncoHealth Corp Recent Developments and Future Plans
• 2.8 Danaher
  • 2.8.1 Danaher Details
  • 2.8.2 Danaher Major Business
  • 2.8.3 Danaher Point-of-care Cancer Screening Product and Solutions
  • 2.8.4 Danaher Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.8.5 Danaher Recent Developments and Future Plans
• 2.9 NOVIGENIX SA
  • 2.9.1 NOVIGENIX SA Details
  • 2.9.2 NOVIGENIX SA Major Business
  • 2.9.3 NOVIGENIX SA Point-of-care Cancer Screening Product and Solutions
  • 2.9.4 NOVIGENIX SA Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.9.5 NOVIGENIX SA Recent Developments and Future Plans
• 2.10 Quidel Corporation
  • 2.10.1 Quidel Corporation Details
  • 2.10.2 Quidel Corporation Major Business
  • 2.10.3 Quidel Corporation Point-of-care Cancer Screening Product and Solutions
  • 2.10.4 Quidel Corporation Point-of-care Cancer Screening Revenue, Gross Margin and Market Share (2018-2023)
  • 2.10.5 Quidel Corporation Recent Developments and Future Plans

3 Market Competition, by Players

• 3.1 Global Point-of-care Cancer Screening Revenue and Share by Players (2018-2023)
• 3.2 Market Share Analysis (2022)
  • 3.2.1 Market Share of Point-of-care Cancer Screening by Company Revenue
  • 3.2.2 Top 3 Point-of-care Cancer Screening Players Market Share in 2022
  • 3.2.3 Top 6 Point-of-care Cancer Screening Players Market Share in 2022
• 3.3 Point-of-care Cancer Screening Market: Overall Company Footprint Analysis
  • 3.3.1 Point-of-care Cancer Screening Market: Region Footprint
  • 3.3.2 Point-of-care Cancer Screening Market: Company Product Type Footprint
  • 3.3.3 Point-of-care Cancer Screening Market: Company Product Application Footprint
• 3.4 New Market Entrants and Barriers to Market Entry
• 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

• 4.1 Global Point-of-care Cancer Screening Consumption Value and Market Share by Type (2018-2023)
• 4.2 Global Point-of-care Cancer Screening Market Forecast by Type (2024-2029)

5 Market Size Segment by Application

• 5.1 Global Point-of-care Cancer Screening Consumption Value Market Share by Application (2018-2023)
• 5.2 Global Point-of-care Cancer Screening Market Forecast by Application (2024-2029)

6 North America

• 6.1 North America Point-of-care Cancer Screening Consumption Value by Type (2018-2029)
• 6.2 North America Point-of-care Cancer Screening Consumption Value by Application (2018-2029)
• 6.3 North America Point-of-care Cancer Screening Market Size by Country
  • 6.3.1 North America Point-of-care Cancer Screening Consumption Value by Country (2018-2029)
  • 6.3.2 United States Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 6.3.3 Canada Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 6.3.4 Mexico Point-of-care Cancer Screening Market Size and Forecast (2018-2029)

7 Europe

• 7.1 Europe Point-of-care Cancer Screening Consumption Value by Type (2018-2029)
• 7.2 Europe Point-of-care Cancer Screening Consumption Value by Application (2018-2029)
• 7.3 Europe Point-of-care Cancer Screening Market Size by Country
  • 7.3.1 Europe Point-of-care Cancer Screening Consumption Value by Country (2018-2029)
  • 7.3.2 Germany Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 7.3.3 France Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 7.3.4 United Kingdom Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 7.3.5 Russia Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 7.3.6 Italy Point-of-care Cancer Screening Market Size and Forecast (2018-2029)

8 Asia-Pacific

• 8.1 Asia-Pacific Point-of-care Cancer Screening Consumption Value by Type (2018-2029)
• 8.2 Asia-Pacific Point-of-care Cancer Screening Consumption Value by Application (2018-2029)
• 8.3 Asia-Pacific Point-of-care Cancer Screening Market Size by Region
  • 8.3.1 Asia-Pacific Point-of-care Cancer Screening Consumption Value by Region (2018-2029)
  • 8.3.2 China Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 8.3.3 Japan Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 8.3.4 South Korea Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 8.3.5 India Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 8.3.6 Southeast Asia Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 8.3.7 Australia Point-of-care Cancer Screening Market Size and Forecast (2018-2029)

9 South America

• 9.1 South America Point-of-care Cancer Screening Consumption Value by Type (2018-2029)
• 9.2 South America Point-of-care Cancer Screening Consumption Value by Application (2018-2029)
• 9.3 South America Point-of-care Cancer Screening Market Size by Country
  • 9.3.1 South America Point-of-care Cancer Screening Consumption Value by Country (2018-2029)
  • 9.3.2 Brazil Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 9.3.3 Argentina Point-of-care Cancer Screening Market Size and Forecast (2018-2029)

10 Middle East & Africa

• 10.1 Middle East & Africa Point-of-care Cancer Screening Consumption Value by Type (2018-2029)
• 10.2 Middle East & Africa Point-of-care Cancer Screening Consumption Value by Application (2018-2029)
• 10.3 Middle East & Africa Point-of-care Cancer Screening Market Size by Country
  • 10.3.1 Middle East & Africa Point-of-care Cancer Screening Consumption Value by Country (2018-2029)
  • 10.3.2 Turkey Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 10.3.3 Saudi Arabia Point-of-care Cancer Screening Market Size and Forecast (2018-2029)
  • 10.3.4 UAE Point-of-care Cancer Screening Market Size and Forecast (2018-2029)

11 Market Dynamics

• 11.1 Point-of-care Cancer Screening Market Drivers
• 11.2 Point-of-care Cancer Screening Market Restraints
• 11.3 Point-of-care Cancer Screening Trends Analysis
• 11.4 Porters Five Forces Analysis
  • 11.4.1 Threat of New Entrants
  • 11.4.2 Bargaining Power of Suppliers
  • 11.4.3 Bargaining Power of Buyers
  • 11.4.4 Threat of Substitutes
  • 11.4.5 Competitive Rivalry
• 11.5 Influence of COVID-19 and Russia-Ukraine War
  • 11.5.1 Influence of COVID-19
  • 11.5.2 Influence of Russia-Ukraine War

12 Industry Chain Analysis

• 12.1 Point-of-care Cancer Screening Industry Chain
• 12.2 Point-of-care Cancer Screening Upstream Analysis
• 12.3 Point-of-care Cancer Screening Midstream Analysis
• 12.4 Point-of-care Cancer Screening Downstream Analysis

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Research Process and Data Source